Assignee
SEQIRUS UK LTD
GB·27 granted patents·30 pending applications·25 citations·filing 2013–2025
Top patents by PatentIndex Score
57 records- 0192US9801935B2Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2016·Granted Oct 31, 2017·3 cites·10 claims
- 0292US2025288660A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2024·Application pending·0 cites
- 0390US11406701B2Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2020·Granted Aug 9, 2022·3 cites·20 claims
- 0489US2024424081A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2024·Application pending·0 cites
- 0588US10149901B2Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2016·Granted Dec 11, 2018·3 cites·24 claims
- 0685US11246921B2Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2019·Granted Feb 15, 2022·1 cites·20 claims
- 0783US11013795B2Antigenically matched influenza vaccinesSEQIRUS UK LTD·Filed 2016·Granted May 25, 2021·2 cites·23 claims
- 0883US2023398203A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2022·Application pending·0 cites
- 0980US9708585B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2013·Granted Jul 18, 2017·4 cites·6 claims
- 1080US9566326B2Adjuvanted influenza vaccines for pediatric useSEQIRUS UK LTD·Filed 2013·Granted Feb 14, 2017·3 cites·11 claims
- 1176US10030231B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Jul 24, 2018·2 cites·33 claims
- 1275US10112979B2Influenza vaccinationSEQIRUS UK LTD·Filed 2015·Granted Oct 30, 2018·1 cites·20 claims
- 1375US2024299537A1Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell cultureSEQIRUS UK LTD·Filed 2023·Application pending·0 cites
- 1474US2026000748A1Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2025·Application pending·0 cites
- 1574US2022323577A1Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccinesSEQIRUS UK LTD·Filed 2021·Application pending·0 cites
- 1671US12558412B2Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2025·Granted Feb 24, 2026·0 cites·20 claims
- 1771US2026048115A1Preparation of influenza virus vaccine antigensSEQIRUS UK LTD·Filed 2025·Application pending·0 cites
- 1870US2018250381A1Soluble needle arrays for delivery of influenza vaccinesSEQIRUS UK LTD·Filed 2017·Application pending·0 cites
- 1969US10946088B2Preparation of influenza virus vaccine antigensSEQIRUS UK LTD·Filed 2015·Granted Mar 16, 2021·1 cites·22 claims
- 2068US10864264B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Granted Dec 15, 2020·0 cites·42 claims
- 2167US11249088B2Influenza potency assaysSEQIRUS UK LTD·Filed 2019·Granted Feb 15, 2022·0 cites·20 claims
- 2267US9901630B2Adjuvant-sparing multi-dose influenza vaccination regimenSEQIRUS UK LTD·Filed 2014·Granted Feb 27, 2018·1 cites·22 claims
- 2367US2024050553A1Making influenza virus vaccines without using eggsSEQIRUS UK LTD·Filed 2023·Application pending·0 cites
- 2467US2024342267A1Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2023·Application pending·0 cites
- 2566US12318442B2Preparation of influenza virus vaccine antigensSEQIRUS UK LTD·Filed 2021·Granted Jun 3, 2025·0 cites·19 claims
- 2666US10329537B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Jun 25, 2019·1 cites·7 claims
- 2766US9574181B2Influenza virus reassortment methodSEQIRUS UK LTD·Filed 2014·Granted Feb 21, 2017·0 cites·10 claims
- 2866US2020155666A1Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 2966US2019167786A1Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccinesSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 3065US10610584B2Reverse genetics systemsSEQIRUS UK LTD·Filed 2017·Granted Apr 7, 2020·0 cites·21 claims
- 3163US10716844B2Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2020·Granted Jul 21, 2020·0 cites·15 claims
- 3262US11707520B2Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell cultureSEQIRUS UK LTD·Filed 2020·Granted Jul 25, 2023·0 cites·20 claims
- 3361US11896660B1Reducing hospitalization in elderly influenza vaccine recipientsSEQIRUS UK LTD·Filed 2017·Granted Feb 13, 2024·0 cites·21 claims
- 3460US11897918B2Compositions and methods to increase productionSEQIRUS UK LTD·Filed 2019·Granted Feb 13, 2024·0 cites·14 claims
- 3558US12083175B1Enhancement of self-amplifying mRNA molecules within lipid nanoparticlesSEQIRUS UK LTD·Filed 2021·Granted Sep 10, 2024·0 cites·29 claims
- 3658US11466257B2Cell-derived viral vaccines with low levels of residual cell DNASEQIRUS UK LTD·Filed 2020·Granted Oct 11, 2022·0 cites·13 claims
- 3758US2019142929A1Influenza vaccine regimens for pandemic associated strainsSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 3858US2019382854A1Generic assays for detection of influenza virusesSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 3957US2023218526A1Cold filtration of oil-in-water emulsion adjuvantsSEQIRUS UK LTD·Filed 2021·Application pending·0 cites
- 4056US2019134186A1Influenza vaccines with reduced amount of emulsion adjuvantSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 4155US10500266B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2017·Granted Dec 10, 2019·0 cites·23 claims
- 4255US10232031B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Mar 19, 2019·0 cites·12 claims
- 4355US2020000909A1Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 4454US2019167780A1Influenza virus vaccinesSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 4554US2022168413A1Adjuvanted multivalent influenza vaccinesSEQIRUS UK LTD·Filed 2020·Application pending·0 cites
- 4654US2018207258A1Adjuvanted influenza vaccines for pediatric useSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 4754US2017202955A1Adjuvanted Influenza Vaccines for Pediatric UseSEQIRUS UK LTD·Filed 2016·Application pending·0 cites
- 4853US2019284575A1Reverse genetics using non-endogenous pol i promotersSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 4953US2019142927A1Low-additive influenza vaccinesSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 5051US2017304429A1Vaccination of immunocompromised subjectsSEQIRUS UK LTD·Filed 2015·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SEQIRUS UK LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →